PharmaResearch Co., Ltd. (KOSDAQ:214450)
367,500
+5,000 (1.38%)
Apr 18, 2025, 3:30 PM KST
PharmaResearch Revenue
In the year 2024, PharmaResearch had annual revenue of 350.12B KRW with 34.14% growth. PharmaResearch had revenue of 103.08B in the quarter ending December 31, 2024, with 47.34% growth.
Revenue
350.12B
Revenue Growth
+34.14%
P/S Ratio
10.91
Revenue / Employee
856.03M
Employees
409
Market Cap
3,818.20B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 350.12B | 89.10B | 34.14% |
Dec 31, 2023 | 261.01B | 66.25B | 34.02% |
Dec 31, 2022 | 194.76B | 40.68B | 26.40% |
Dec 31, 2021 | 154.08B | 45.34B | 41.69% |
Dec 31, 2020 | 108.75B | 24.87B | 29.66% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,547.32B |
Celltrion | 3,557.30B |
ALTEOGEN | 102.85B |
Yuhan | 2,067.79B |
SK Biopharmaceuticals | 547.60B |
HLB Co., Ltd. | 68.13B |
LigaChem Biosciences | 125.90B |
Peptron | 3.15B |